These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2396995)

  • 41. Molecular mechanism of kininogen deficiency in brown Norway Katholiek rats.
    Oh-ishi S; Hayashi I; Hosiko S; Makabe O
    Braz J Med Biol Res; 1994 Aug; 27(8):1803-15. PubMed ID: 7749370
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selective inhibition of thrombin- and plasmin-induced platelet aggregation by a synthetic peptide disulfide.
    Puri RN; Hu CJ; Bradford HN; Matsueda R; Umeyama H; Colman RW
    Trans Assoc Am Physicians; 1989; 102():13-9. PubMed ID: 2561638
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Platelet thrombospondin interactions with human high and low molecular weight kininogens.
    DeLa Cadena RA; Wyshock EG; Kunapuli SP; Schultze RL; Miller M; Walz DA; Colman RW
    Thromb Haemost; 1994 Jul; 72(1):125-31. PubMed ID: 7974360
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic basis of total kininogen deficiency in Williams' trait.
    Cheung PP; Kunapuli SP; Scott CF; Wachtfogel YT; Colman RW
    J Biol Chem; 1993 Nov; 268(31):23361-5. PubMed ID: 7901207
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Kininogens as inhibitors of calpains: characteristics and biological implications of the reaction.
    Sasaki M; Ohkubo I; Kunimatsu M
    Agents Actions Suppl; 1992; 38 ( Pt 1)():267-76. PubMed ID: 1466279
    [No Abstract]   [Full Text] [Related]  

  • 46. High molecular weight kininogen: localization in the unstimulated and activated platelet and activation by a platelet calpain(s).
    Schmaier AH; Smith PM; Purdon AD; White JG; Colman RW
    Blood; 1986 Jan; 67(1):119-30. PubMed ID: 3000474
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Attenuated kinin release from human neutrophil elastase-pretreated kininogens by tissue and plasma kallikreins.
    Dulinski R; Suder P; Guevara-Lora I; Rapała-Kozik M; Potempa J; Silberring J; Imamura T; Travis J; Kozik A
    Biol Chem; 2003 Jun; 384(6):929-37. PubMed ID: 12887060
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High molecular weight kininogen protects human plasma kallikrein and factor XIa against inactivation by plasma protease inhibitors.
    Schapira M; Scott CF; Colman RW
    Trans Assoc Am Physicians; 1981; 94():190-7. PubMed ID: 6979819
    [No Abstract]   [Full Text] [Related]  

  • 49. Properties of chemically oxidized kininogens.
    Nieziołek M; Kot M; Pyka K; Mak P; Kozik A
    Acta Biochim Pol; 2003; 50(3):753-63. PubMed ID: 14515155
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular characterization of total kininogen deficiency in Japanese patients.
    Ishimaru F; Dansako H; Nakase K; Fujii N; Sezaki N; Nakayama H; Fujii N; Komiyama Y; Iijima K; Takenaka K; Teshima T; Shinagawa K; Ikeda K; Niiya K; Harada M
    Int J Hematol; 1999 Feb; 69(2):126-8. PubMed ID: 10071463
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High molecular weight kininogen or its light chain protects human plasma kallikrein from inactivation by plasma protease inhibitors.
    Schapira M; Scott CF; James A; Silver LD; Kueppers F; James HL; Colman RW
    Biochemistry; 1982 Feb; 21(3):567-72. PubMed ID: 6175341
    [No Abstract]   [Full Text] [Related]  

  • 52. Demonstration of high-molecular-weight kininogen in kininogen-deficient rat kidneys.
    Mimura T; Hayashi I; Hoshino T; Oh-ishi S
    J Biochem; 1994 Jul; 116(1):59-63. PubMed ID: 7798187
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of cell adhesion by high molecular weight kininogen.
    Asakura S; Hurley RW; Skorstengaard K; Ohkubo I; Mosher DF
    J Cell Biol; 1992 Jan; 116(2):465-76. PubMed ID: 1370494
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Kinetic analysis of the role of zinc in the interaction of domain 5 of high-molecular weight kininogen (HK) with heparin.
    Lin Y; Pixley RA; Colman RW
    Biochemistry; 2000 May; 39(17):5104-10. PubMed ID: 10819977
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulation of factor XIa activity by platelets and alpha 1-protease inhibitor.
    Walsh PN; Sinha D; Kueppers F; Seaman FS; Blankstein KB
    J Clin Invest; 1987 Dec; 80(6):1578-86. PubMed ID: 3500185
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Receptors for high molecular weight kininogen on stimulated washed human platelets.
    Greengard JS; Griffin JH
    Biochemistry; 1984 Dec; 23(26):6863-9. PubMed ID: 6099145
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prothrombin is a cofactor for the binding of factor XI to the platelet surface and for platelet-mediated factor XI activation by thrombin.
    Baglia FA; Walsh PN
    Biochemistry; 1998 Feb; 37(8):2271-81. PubMed ID: 9485373
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Calpain and kininogen mediated inflammation.
    Sasaki M; Kunimatsu M; Tada T; Nishimura J; Ma XJ; Ohkubo I
    Biomed Biochim Acta; 1991; 50(4-6):499-508. PubMed ID: 1801715
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Kinetic analysis of the interaction of human tissue kallikrein with single-chain human high and low molecular weight kininogens.
    Maier M; Austen KF; Spragg J
    Proc Natl Acad Sci U S A; 1983 Jul; 80(13):3928-32. PubMed ID: 6575386
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neutrophil adhesion on polyurethanes preadsorbed with high molecular weight kininogen.
    Yung LY; Colman RW; Cooper SL
    Blood; 1999 Oct; 94(8):2716-24. PubMed ID: 10515875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.